Title	Hydroxychloroquine in ANCA Vasculitis Evaluation - A Multicentre, Randomised, Double-blind, Placebo-controlled Trial (HAVEN)
Trial registration	ISRCTN: ISRCTN79334891 EudraCT: 2018-001268-40 Clinicaltrials.gov: NCT04316494
Protocol version	6.0 dated 10/05/2022
Funding	The trial is funded by the Medical Research Council (Grant Ref: MR/R006253/1).
Author details	1School of Life Course and Population Sciences, Faculty of Life Sciences & Medicine. King’s College London, UK 2 Clinical Trial Manager Platform, Guy’s and St Thomas’ NHS Foundation Trust, UK 3 Louise Coote Lupus Unit, Rheumatology Department, Guy’s and St Thomas’ NHS Foundation Trust, UK 4 King’s Clinical Trial Unit, Research Management and Innovation Directorate, King’s College London, UK 5 Dept. of Immunology, School of Immunology & Microbial Sciences, King's College London, UK 6 Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Science, University of Oxford, UK 7 Department of Medicine, University of Cambridge, UK 8 Centre for Rheumatic Disease, Kings College London, UK
Name and contact information for the trial sponsor	Guy’s and St. Thomas’ NHS Foundation Trust (GSTT) Sponsor Contact: Amy Holton Address: King’s Health Partners Clinical Trials Office 16th Floor Tower Wing Guy’s Hospital London SE1 9RT Telephone: 02071885732 Fax: 02071888330 Email: amy.holton@kcl.ac.uk
Role of sponsor	GSTT is responsible for ensuring that the trial respects the dignity, rights, safety and well-being of participants. Neither the trial sponsor nor funder had direct involvement in the trial design, writing of the report, nor will they be involved in the analysis, management, interpretation and publication of the data.